Insulin Resistance and Insulin Handling in Chronic Kidney Disease

被引:6
|
作者
Parvathareddy, Vishnu P. [1 ]
Wu, Jiao [1 ]
Thomas, Sandhya S. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Med, Nephrol Div, Houston, TX 77030 USA
[2] Michael E Debakey VA Med Ctr, Dept Med, Nephrol Div, Houston, TX 77030 USA
关键词
IMPAIRED GLUCOSE-TOLERANCE; ACTIVATED PROTEIN-KINASE; CKD STAGES 3; METABOLIC SYNDROME; CLINICAL-OUTCOMES; METFORMIN USE; RISK-FACTORS; RECEPTOR; SENSITIVITY; MUSCLE;
D O I
10.1002/cphy.c220019
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Insulin regulates energy metabolism involving multiple organ systems. Insulin resistance (IR) occurs when organs exhibit reduced insulin sensitivity, leading to difficulties in maintaining glucose homeostasis. IR ensures decades prior to development of overt diabetes and can cause silent metabolic derangements. IR is typically seen very early in the course of chronic kidney disease (CKD) and is evident even when the estimated glomerular filtration rate (eGFR) is within the normal range and IR persists at various stages of kidney disease. In this article, we will discuss insulin handling by the kidneys, mechanisms responsible for IR in CKD, measurements and management of IR in patients with CKD, and recent type 2 diabetic trials with implications for improved cardiovascular outcomes in CKD.
引用
收藏
页码:5069 / 5076
页数:8
相关论文
共 50 条
  • [31] Insulin resistance and chronic liver disease
    Takumi Kawaguchi
    Eitaro Taniguchi
    Minoru Itou
    Masahiro Sakata
    Shuji Sumie
    Michio Sata
    World Journal of Hepatology, 2011, 3 (05) : 99 - 107
  • [32] Insulin resistance and chronic liver disease
    Kawaguchi, Takumi
    Taniguchi, Eitaro
    Itou, Minoru
    Sakata, Masahiro
    Sumie, Shuji
    Sata, Michio
    WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (05) : 99 - 107
  • [33] Insulin Resistance, Inflammation, and Vascular Disease in Nondiabetic Predialysis Chronic Kidney Disease Patients
    Banerjee, Debasish
    Recio-Mayoral, Alejandro
    Chitalia, Nihil
    Kaski, Juan-Carlos
    CLINICAL CARDIOLOGY, 2011, 34 (06) : 360 - 365
  • [34] Insulin resistance in chronic kidney disease: new lessons from experimental models
    Koppe, Laetitia
    Pelletier, Caroline C.
    Alix, Pascaline M.
    Kalbacher, Emilie
    Fouque, Denis
    Soulage, Christophe O.
    Guebre-Egziabher, Fitsum
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (09) : 1666 - 1674
  • [35] Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field
    Dave, Natasha
    Wu, Jiao
    Thomas, Sandhya
    CURRENT DIABETES REPORTS, 2018, 18 (07)
  • [36] Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field
    Natasha Dave
    Jiao Wu
    Sandhya Thomas
    Current Diabetes Reports, 2018, 18
  • [37] MTORC1 SIGNALING IN INSULIN RESISTANCE RATS WITH CHRONIC KIDNEY DISEASE
    Zhang, Li
    Li, Jiao
    Xu, Zhuo
    Zhao, Yang
    Chen, Xiangmei
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [38] Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions
    Chan, Doris T.
    Watts, Gerald F.
    Irish, Ashley B.
    Dogra, Gursharan K.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (08) : 1274 - 1281
  • [39] Insulin resistance, inflammatory biomarkers and adipokines in chronic kidney disease (CKD) patients
    Garcia de Vinuesa, Soledad
    Goicoechea, Marian
    Vega, Almudena
    Abad, Soraya
    Gomez, Francisco
    Cachofeiro, Victoria
    Lahera, Vicente
    Luno, Jose
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 64 - 65
  • [40] Retention of acetylcarnitine in chronic kidney disease causes insulin resistance in skeletal muscle
    Miyamoto, Yasunori
    Miyazaki, Teruo
    Honda, Akira
    Shimohata, Homare
    Hirayama, Kouichi
    Kobayashi, Masaki
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2016, 59 (03) : 199 - 206